{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:30:41Z","timestamp":1786987841695,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eclinm.2023.102404","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T17:45:50Z","timestamp":1704476750000},"page":"102404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-1077","authenticated-orcid":false,"given":"Christian","family":"Schoergenhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Gelbenegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzenita","family":"Hasanacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Sch\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete M.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Firbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Buchtele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Derhaschnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tanzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Model","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Larcher-Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Drost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.eclinm.2023.102404_bib1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198012183032501","article-title":"Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention","volume":"303","author":"Davis","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102404_bib2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00134-015-3861-7","article-title":"Understanding toxic shock syndrome","volume":"41","author":"Burnham","year":"2015","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102404_bib3","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S1473-3099(19)30041-6","article-title":"Menstrual toxic shock syndrome: case report and systematic review of the literature","volume":"19","author":"Berger","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102404_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022997","article-title":"Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics","volume":"6","author":"DeVries","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2023.102404_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100308","article-title":"Association of characteristics of tampon use with menstrual toxic shock syndrome in France","volume":"21","author":"Billon","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102404_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/cid\/ciab378","article-title":"Menstrual toxic shock syndrome: a French nationwide multicenter retrospective study","volume":"74","author":"Contou","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2023.102404_bib7","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/clinids\/11.Supplement_1.S28","article-title":"Active surveillance for toxic shock syndrome in the United States, 1986","volume":"11","author":"Gaventa","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102404_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/148.4.692","article-title":"Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome","volume":"148","author":"Vergeront","year":"1983","journal-title":"J\u00a0Infect Dis"},{"issue":"6 Pt 2","key":"10.1016\/j.eclinm.2023.102404_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-96-6-871","article-title":"Nonmenstrual toxic shock syndrome: a review of 130 cases","volume":"96","author":"Reingold","year":"1982","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102404_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10096-007-0405-2","article-title":"One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases","volume":"27","author":"Descloux","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9-10","key":"10.1016\/j.eclinm.2023.102404_bib11","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0264-410X(01)00470-4","article-title":"Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome","volume":"20","author":"Gampfer","year":"2002","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102404_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1473-3099(16)30115-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial","volume":"16","author":"Schwameis","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102404_bib13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/infdis\/174.6.1261","article-title":"A\u00a0mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity","volume":"174","author":"Kum","year":"1996","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102404_bib14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4049\/jimmunol.171.3.1385","article-title":"Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II\/superantigen\/TCR ternary complexes","volume":"171","author":"McCormick","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102404_bib15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3390\/toxins6061724","article-title":"Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in\u00a0vivo and in\u00a0vitro exposure","volume":"6","author":"Stich","year":"2014","journal-title":"Toxins (Basel)"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102404_bib16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14760584.2013.840091","article-title":"Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage","volume":"12","author":"Botelho-Nevers","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102404_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrmicro3308","article-title":"Models matter: the search for an effective staphylococcus aureus vaccine","volume":"12","author":"Salgado-Pabon","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102404_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1189\/jlb.0108074","article-title":"Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1","volume":"85","author":"Waclavicek","year":"2009","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102404_bib19","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1093\/cid\/ciac169","article-title":"Antibody response in immunocompromised patients after the administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine BNT162b2 or mRNA-1273: a randomized controlled trial","volume":"75","author":"Speich","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102404_bib20","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"27","key":"10.1016\/j.eclinm.2023.102404_bib21","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102404_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0037-2018","article-title":"Immunity to Staphylococcus aureus: implications for vaccine development","volume":"7","author":"Proctor","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"4956","key":"10.1016\/j.eclinm.2023.102404_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.2185544","article-title":"The staphylococcal enterotoxins and their relatives","volume":"248","author":"Marrack","year":"1990","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102404_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pathogens7020053","article-title":"Manipulation of innate and adaptive immunity by staphylococcal superantigens","volume":"7","author":"Tuffs","year":"2018","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102404_bib25","doi-asserted-by":"crossref","first-page":"e00214","DOI":"10.1128\/mBio.00214-19","article-title":"Staphylococcal superantigens stimulate epithelial cells through CD40 to produce chemokines","volume":"10","author":"Schlievert","year":"2019","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102404_bib26","first-page":"275","article-title":"Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam","volume":"74","author":"Hong","year":"1996","journal-title":"Bull World Health Organ"},{"issue":"19","key":"10.1016\/j.eclinm.2023.102404_bib27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"8228","key":"10.1016\/j.eclinm.2023.102404_bib28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(81)92186-3","article-title":"A\u00a0new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates","volume":"1","author":"Bergdoll","year":"1981","journal-title":"Lancet"},{"issue":"6 Pt 2","key":"10.1016\/j.eclinm.2023.102404_bib29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-96-6-969","article-title":"An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome","volume":"96","author":"Bergdoll","year":"1982","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102404_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/CVI.00399-16","article-title":"Safety and immunogenicity of a parenterally administered, structure-based rationally modified recombinant staphylococcal enterotoxin B protein vaccine, STEBVax","volume":"23","author":"Chen","year":"2016","journal-title":"Clin Vaccine Immunol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:21:35Z","timestamp":1762899695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023005813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":30,"alternative-id":["S2589537023005813"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102404","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102404"}}